Search Share Prices
Concepta claims 'step change' for manufacturing plans
Healthcare company Concepta plans to bump up its production rate after achieving ISO13485 certification for its manufacturing site in Doncaster.
The ISO certification was seen by the firm as a "significant step-change" in its operations, allowing the company to utilise the automated production lines recently installed at its Doncaster facility to begin manufacturing its myLotus diagnostic tests.
Concepta, primarily a developer of a proprietary product targeted at the mobile health market with a key focus on women's fertility also advised investors on Monday that it expects to transfer the remaining manual assembly capability, currently located at its Colworth labs, to the Doncaster facility during April 2018, enabling all of its manufacturing to be carried out at the specially designed facility.
Erik Henau, Concepta's chief executive, said, "It is a great achievement for the team to reach this key milestone following the myLotus pre-launch in the UK. This development is important in enabling the company to operate with greater capacity and improved efficiency at one site and is a crucial step towards offering myLotus direct to consumers here in the UK."
As of 0920 BST, shares remained unmoved at 5.45p.